Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03400787 · ClinicalTrials.gov registry record · NA
Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse
A NA study of Nasal Valve Collapse and Nasal Breathing, sponsored by Spirox.
- Completed
- Registry status
- NA
- Development phase
- 137
- Enrollment target
- 11
- Study locations
NCT03400787 is a NA study of Nasal Valve Collapse and Nasal Breathing that has completed, run by Spirox. The registered enrollment target is 137 participants. The trial reports 11 study locations across 8 states.
The verdict
NCT03400787, a NA study of Nasal Valve Collapse and Nasal Breathing, has completed, sponsored by Spirox.
- COMPLETED
- Registry status
- NA
- Development phase
- 137 participants
- Enrollment target
- 11
- Study locations
Study Summary
The primary objective of the LATERA RCT is to demonstrate the superiority of the Latera Implant to improve nasal breathing, compared with a Sham Control procedure.
Conditions Studied
Interventions
- DEVICE Sham Procedure
- DEVICE Latera Implant
Study Locations (11)
Texas
- Texas ENT Specialist - Houston
- ENT Associates of Texas - McKinney
- Texas Facial Plastics and ENT - San Antonio
California
- Sacramento ENT - Roseville
- Breathe Clear Institute - Torrance
Georgia
- ENT of GA - Atlanta
Illinois
- Chicago Nasal and Sinus Center - Chicago
Indiana
- Michiana Sleep and ENT Solutions - South Bend
New York
- Albany ENT & Allergy - Albany
North Carolina
- Piedmont ENT - Winston-Salem
Utah
- Ogden Clinic - Ogden
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 137 participants |
| Start Date | 2017-11-28 |
| Est. Completion | 2020-12-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03400787
The ClinicalTrials.gov registry entry for NCT03400787 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 137 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Spirox, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Nasal Valve Collapse appearing as the primary indexed condition, and to 2 interventions - of which Sham Procedure is the first listed.
NCT03400787 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Texas, California, Georgia.
Frequently Asked Questions
What is clinical trial NCT03400787 about?
NCT03400787 is a clinical study titled "Latera RCT - Latera vs. Sham Control for Lateral Nasal Valve Collapse". The primary objective of the LATERA RCT is to demonstrate the superiority of the Latera Implant to improve nasal breathing, compared with a Sham Control procedure.
What is the current status of trial NCT03400787?
This trial is currently completed. It is a NA study. The enrollment target is 137 participants. The study started on 2017-11-28. Estimated completion is 2020-12-23.
What conditions does trial NCT03400787 study?
This clinical trial studies the following conditions: Nasal Valve Collapse, Nasal Breathing.
What interventions are being tested in trial NCT03400787?
The interventions under investigation include: Sham Procedure (DEVICE), Latera Implant (DEVICE).
Who is sponsoring clinical trial NCT03400787?
This trial is sponsored by Spirox, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03400787 being conducted?
This trial has 11 study locations across California, Georgia, Illinois, Indiana, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nasal Valve Collapse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.